Nitro-dur Patch
Product Images NDC 50742-515

18 FDA label images from Ingenus Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Nitro-dur (NDC 50742-515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nitroglycerin Chemical Structure (Nitro Dur 01)

Nitroglycerin Chemical Structure (Nitro Dur 01)
Chemical structure diagram showing a molecule with H2CONO2 and HCONO2 groups, likely related to nitroglycerin, the active ingredient in NITRO-DUR transdermal patches by Ingenus Pharmaceuticals.*
FDA Label Image

Cross Section Of System (Nitro Dur 02)

Cross Section Of System (Nitro Dur 02)
An illustration of a transdermal patch showing its layered construction. The top layer is labeled 'Impermeable Backing,' and below it is a layer labeled 'Nitroglycerin/Adhesive,' indicating the patch contains nitroglycerin embedded in an adhesive for skin application.*
FDA Label Image

Placement Area Image (Nitro Dur 03)

Placement Area Image (Nitro Dur 03)
An instructional diagram showing the correct placement of a transdermal patch on the upper chest area of a person. The illustration highlights a gray patch placed on the upper chest, just below the neck and to the left side.*
FDA Label Image

Application Figure Image (Nitro Dur 04)

Application Figure Image (Nitro Dur 04)
An instructional illustration showing hands applying or removing a circular transdermal patch, likely demonstrating proper use or handling of the product.*
FDA Label Image

Application Figure Image (Nitro Dur 05)

Application Figure Image (Nitro Dur 05)
Instructional illustration showing hands applying or removing a NITRO-DUR transdermal patch, depicting the method for correct placement or removal from the skin. The image includes a close-up outline of a body area, likely the chest or upper arm, where the patch is to be applied.*
FDA Label Image

Application Figure Image (Nitro Dur 06)

Application Figure Image (Nitro Dur 06)
An instructional illustration showing the application of a transdermal patch. The diagram depicts a person placing a rectangular patch on the upper arm or shoulder area, demonstrating proper placement for a NITRO-DUR nitroglycerin transdermal patch.*
FDA Label Image

Application Figure Image (Nitro Dur 07)

Application Figure Image (Nitro Dur 07)
An instructional illustration showing a hand applying a round transdermal patch to the skin, likely demonstrating how to use a nitroglycerin patch such as NITRO-DUR. The image is in grayscale and depicts the patch placement technique.*
FDA Label Image

Application Figure Image (Nitro Dur 08)

Application Figure Image (Nitro Dur 08)
An instructional diagram showing a hand applying a circular patch to the skin, illustrating the proper method to remove the protective backing from a transdermal patch before application. No specific product branding is visible in the image itself.*
FDA Label Image

Application Figure Image (Nitro Dur 09)

Application Figure Image (Nitro Dur 09)
An illustration demonstrating the proper application of the NITRO-DUR transdermal patch on the upper arm. The diagram shows a person placing the patch on the skin, highlighting the location and method for usage of the nitroglycerin patch. No additional textual information is visible.*
FDA Label Image

Application Figure Image (Nitro Dur 10)

Application Figure Image (Nitro Dur 10)
NITRO-DUR nitroglycerin transdermal patch packaging shows a primarily white and gray background with the patch partially visible on the right side of the image. There is a circular cut-out on the left. The labeler is Ingenus Pharmaceuticals, LLC. Specific strength or quantity details are not visible.*
FDA Label Image

Removal Figure Image (Nitro Dur 11)

Removal Figure Image (Nitro Dur 11)
An instructional illustration showing a hand holding a NITRO-DUR transdermal patch. The image depicts application steps, including handling the patch carefully by its edges and preparing it for placement on the skin.*
FDA Label Image

Removal Figure Image (Nitro Dur 12)

Removal Figure Image (Nitro Dur 12)
An instructional illustration showing a hand holding a round transdermal patch with a peel-off backing. The image demonstrates the removal of the protective liner from the adhesive patch, typically used for applying a nitroglycerin patch such as NITRO-DUR.*
FDA Label Image

Nitro-dur 0.1 mg/hr (Nitro Dur 13 V02)

Nitro-dur 0.1 mg/hr (Nitro Dur 13 V02)
NITRO-DUR (nitroglycerin) transdermal infusion system patch at a strength of 0.1 mg/hr for a 5 cm² patch size. The label shows usage instructions, directions for application, storage information, and manufacturer details from Ingenus Pharmaceuticals, LLC. The packaging indicates a supply of 30 units.*
FDA Label Image

Nitro-dur 0.2 mg/hr (Nitro Dur 14 V02)

Nitro-dur 0.2 mg/hr (Nitro Dur 14 V02)
NITRO-DUR (nitroglycerin) Transdermal Infusion System patch label shows a 0.2 mg/hr (10 cm²) dosage strength. The label is primarily blue and white, with usage directions, pharmacy label placement, and storage information. It indicates the product is for prescription use only by Ingenus Pharmaceuticals, LLC, with NDC 50742-514-30 and packaging of 30 units.*
FDA Label Image

Nitro-dur 0.3 mg/hr (Nitro Dur 15 V02)

Nitro-dur 0.3 mg/hr (Nitro Dur 15 V02)
NITRO-DUR (nitroglycerin) Transdermal Infusion System patch packaging label showing 0.3 mg/hr (15 cm2) strength. The label includes directions for use, prescribing instructions, and manufacturer Ingenus Pharmaceuticals, LLC. The label features dosage information, NDC 50742-515-30, and indicates the patch contains 60 mg of nitroglycerin in an acrylic-based polymer adhesive.*
FDA Label Image

Nitro-dur 0.4 mg/hr (Nitro Dur 16 V02)

Nitro-dur 0.4 mg/hr (Nitro Dur 16 V02)
NITRO-DUR 0.4 mg/hr (20 cm²) patch packaging label by Ingenus Pharmaceuticals, LLC. It is a transdermal nitroglycerin patch with a transdermal infusion system. The label indicates the product strength and size, contains usage directions on one panel, and includes the NDC 50742-516-30 with 30 units per package. The label is primarily pink and white with black text.*
FDA Label Image

Nitro-dur 0.6 mg/hr (Nitro Dur 17 V02)

Nitro-dur 0.6 mg/hr (Nitro Dur 17 V02)
NITRO-DUR 0.6 mg/hr (30 cm²) nitroglycerin transdermal infusion system packaging label from Ingenus Pharmaceuticals, LLC. The label displays the dosage strength and size, usage directions, and storage conditions. It includes a statement that each unit contains 120 mg of nitroglycerin with specific polymer adhesives and cross-linking agents. The label also has a barcode and prescription-only designation.*
FDA Label Image

Nitro-dur 0.8 mg/hr (Nitro Dur 18 V02)

Nitro-dur 0.8 mg/hr (Nitro Dur 18 V02)
The packaging label for Nitro-Dur (nitroglycerin) Transdermal Infusion System patch, delivering 0.8 mg/hr over 40 cm². Manufactured by Ingenus Pharmaceuticals, LLC, this label is for a unit containing 160 mg nitroglycerin in a polymer adhesive patch. The label features directions for use, pharmacy label placement, and storage instructions, with a yellow and white color scheme and the Ingenus logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.